Biomet Inc. is cooperating with the document requests of the U.S. Department of Justice related to the sales and marketing practices of the Company’s subsidiary, EBI, LLC.
In May 2007, the Company received a subpoena from the DOJ through the U.S.…
The appeal filed by the plaintiffs from the dismissal of their amended consolidated shareholder derivative complaint against certain Biomet Inc. officers and directors is pending with the Indiana Court of Appeals.
On Sept. 21, 2006, two shareholder derivative complaints were…
Biomet Inc. and Biomet Orthopedics, LLC’s lawsuit against Zimmer US, Inc., certain of the Company’s former distributors and David Montgomery is ongoing.
A former employee of the Company, Mr. Montgomery currently works for Zimmer.
The 13-count lawsuit originally filed in…
The Putnam County Circuit Court has scheduled a consolidated trial for June 1, 2009, of six plaintiffs in the remaining lawsuits against Biomet Inc.’s subsidiary, EBI, LLC, Dr. John King, Wright Medical Corporation and Robert Edwards.
In late 2004 and…
The U.S. Securities and Exchange Commission’s investigation into Cardinal Health Inc.’s Executive Chairman of the Board, as well as four former officers and employees, is ongoing.
On Oct. 7, 2003, the Company received a request from the SEC relating to…
Cardinal Health Inc. continues cooperating with the state attorney general offices of Illinois and New York regarding their investigations into a program on repackaged pharmaceuticals.
In October 2005, the Company received a subpoena from the Attorney General’s Office of the State…
Valeant Pharmaceuticals International is in the process of defending Barbara M. Shows’ product liability lawsuit on Permax pending in the Circuit Court of Jefferson Davis County, Miss.
On April 23, 2008, the Company was served a complaint in a case…
Cardinal Health Inc., during the quarter ended June 30, 2008, received the remaining US$35.0 million in net proceeds from the settlement of the derivative actions filed against the Company and certain of its directors and officers.
On Nov. 8, 2002,…
Valeant Pharmaceuticals International, in its Form 10-Q dated Aug. 11, 2008, disclosed that it expects to be dismissed with prejudice from Kathleen M. O’Connor’s product liability lawsuit on Permax soon.
On Feb. 8, 2007, the Company was served with the…
Cardinal Health Inc. and the Drug Enforcement Administration of the U.S. Department of Justice, on Aug. 7, 2008, reached an oral agreement in principle to resolve the license suspensions.
The agreement is subject to the completion of definitive documentation as…